Oryon Cell Therapies https://validator.w3.org/feed/docs/rss2.html Ron Cohen, M.D. Kenny Choi, Ph.D. Team Oryon Cell Therapies Appoints Burkhard Blank, M.D., as Chief Medical Officer Burkhard Blank, M.D. Emmett Cunningham, Jr., M.D., Ph.D., MPH Science Adam Knight, Ph.D., Board Member Ole Isacson, M.D., Ph.D. Nikola Kojic, M.D., Ph.D. Clinical Results Oryon Cell Therapies Reports Phase 1b/2a Data Showing Sustained Motor Improvements in People with Parkinson’s Disease Oryon Cell Therapies Emerges From Stealth Focusing on Autologous Neuron Replacement Therapies for Parkinson’s Disease and Other Neurodegenerative Disorders News Contact Home